HomeAll CategoriesCategory
Biomedical Advanced Development R&D
Total Committed Value of Federal Contracts
$1.54B
Total Contracts
65
Total Actions
118

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description Vendor Agency Effective Estimated completion Amount Committed
ESPEROVAX, INC. ESPEROVAX, INC. Office of Assistant Secretary for Preparedness and Response - HHS July 27, 2020 February 28, 2022 $0
DEVELOP A SAFE AND EFFECTIVE THERAPEUTIC TO MITIGATE SEVERE OUTCOMES, INCLUDING BUT NOT LIMITED TO MORTALITY, IN PATIENTS WITH SEVERE INFECTION OR SEPSIS OF ANY ETIOLOGY. BIOAEGIS THERAPEUTICS INC Office of Assistant Secretary for Preparedness and Response - HHS June 11, 2021 March 31, 2022 $749,000
LUMINEX XMAP SARS-COV-2 MULTI-ANTIGEN ANTIBODY TYPING ASSAY LUMINEX CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS September 23, 2020 July 30, 2021 $0
NCE POP END DATE FROM 30 APRIL 2021 TO 30 SEPTEMBER 2021 - EVIDATION COVID-19 DETECTION & FORECASTING MODEL PILOT EVIDATION HEALTH, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 20, 2020 September 30, 2021 $0
PERAHEALTH COVID-19 RISK TRIAGE TOOL PERAHEALTH, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 15, 2021 February 28, 2022 $686,462
EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC Office of Assistant Secretary for Preparedness and Response - HHS May 24, 2020 December 31, 2021 $22,815,455
EXPANDING PRODUCTION CAPACITY FOR THE PANTHER FUSION SARS-COV-2 ASSAY HOLOGIC, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 29, 2020 April 28, 2021 $0
ASPR-21-00560 - BASE PERIOD FUNDS FOR LUMINEX CORPORATION - EXPAND THE USE OF THE ARIES SARS-COV-2 ASSAY LUMINEX CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS February 18, 2021 February 17, 2022 $11,336,921
COLORADO STATE VACCINE DEVELOPMENT FOR COVID-19 USING SOLAVAX COLORADO STATE UNIVERSITY Office of Assistant Secretary for Preparedness and Response - HHS March 31, 2021 July 30, 2021 $0
IMMUNEXPRESS ASSESSMENT & TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS IMMUNEXPRESS INC. Office of Assistant Secretary for Preparedness and Response - HHS June 11, 2020 December 31, 2021 $0
98POINT6 TEXT-BASED MEDICAL CARE VIA A SMARTPHONE INTERFACE AND ARTIFICIAL INTELLIGENCE TO ASSESS, TRIAGE, DIAGNOSE AND TREAT COVID-19 98POINT6 INC. Office of Assistant Secretary for Preparedness and Response - HHS September 11, 2020 April 30, 2021 $0
DIASORIN LIAISON SARS-COV-2 S1/S2 IGG DIASORIN INC. Office of Assistant Secretary for Preparedness and Response - HHS April 10, 2020 February 03, 2021 $0
DEVELOPMENT OF SIMPLEXA COVID-19 DIRECT ASSAY DIASORIN MOLECULAR LLC Office of Assistant Secretary for Preparedness and Response - HHS March 11, 2020 February 03, 2021 $0
ASPR-21-00574 -- BASE PERIOD FUND TO MBIO DIAGNOSTICS TO DEVELOP THEIR LIGHTDECK SARS-COV ULTRA-RAPID ANTIGEN TEST TO ACHIEVE EUA AND 510K CLEARANCE MBIO DIAGNOSTICS, INC. Office of Assistant Secretary for Preparedness and Response - HHS February 03, 2021 February 02, 2022 $5,654,478
UPDATE CONTRACTOR'S KEYS PERSONNEL EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC Office of Assistant Secretary for Preparedness and Response - HHS May 24, 2020 December 31, 2021 $0
ASPR-21-00523 -- BASE PERIOD FUNDS TO HOLOGIC INC RESPIRATORY PANEL (SARS-COV FLUA FLUB RSV) FOR USE ON THE HOLOGIC PANTHER FUSION SYSTEM HOLOGIC, INC. Office of Assistant Secretary for Preparedness and Response - HHS January 15, 2021 January 13, 2022 $11,414,617
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE OPTIONAL CLIN 0002. CORAM LLC Office of Assistant Secretary for Preparedness and Response - HHS November 25, 2020 February 24, 2021 $494,000
DIASORIN MOLECULAR LLC FOR COVID-19 LABORATORY DIAGNOSTICS - PCR SIMPLEXA DIRECT ASSAYS WITH 510(K) CLEARANCE DIASORIN MOLECULAR LLC Office of Assistant Secretary for Preparedness and Response - HHS January 05, 2021 January 04, 2022 $4,040,000
PILOT STUDY WITH CVS TO INFUSE THIS THERAPY AND MONITOR PATIENTS WITHIN THEIR OWN HOMES, WITH SKILLED NURSING PROFESSIONALS. CORAM LLC Office of Assistant Secretary for Preparedness and Response - HHS November 25, 2020 February 24, 2021 $0
IGF AN NHP EFFICACY STUDY OF BIO 300 FOR MITIGATOR FOR DEARE-INDUCED PNEUMONITIS AND PULMONARY FIBROSIS HUMANETICS CORPORATION National Institutes of Health March 29, 2018 June 30, 2022 $0
EMPATICA EMPACT: EARLY MONITORING PLATFORM AGAINST COVID-19 TRANSMISSION EMPATICA, INC. Office of Assistant Secretary for Preparedness and Response - HHS June 18, 2020 April 30, 2021 $0
ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES NEXELIS LABORATORIES CANADA INC Office of Assistant Secretary for Preparedness and Response - HHS December 08, 2020 December 13, 2021 $712,859
EXTEND THE CONTRACT PURCHASE ORDER PERIOD OF PERFORMANCE AT NO ADDITIONAL COST TO THE GOVERNMENT AND TO CHANGE THE CONTRACTING OFFICER. CHEMBIO DIAGNOSTIC SYSTEMS INC. Office of Assistant Secretary for Preparedness and Response - HHS July 05, 2020 January 29, 2021 $0
DIASORIN SARS-COV-2 TRIMERICS IGG ASSAY & 501(K) VALIDATION DIASORIN INC. Office of Assistant Secretary for Preparedness and Response - HHS November 10, 2020 November 09, 2021 $0
DEVELOPMENT OF DUAL PATH PLATFORM (DPP) COVID-19 ANTIGEN SYSTEM, AS WELL AS ACHIEVEMENT OF EMERGENCY USE AUTHORIZATION (EUA) FROM THE U.S. FOOD AND DRUG ADMINISTRATION (FDA). CHEMBIO DIAGNOSTIC SYSTEMS INC. Office of Assistant Secretary for Preparedness and Response - HHS December 02, 2020 November 30, 2021 $12,691,726
PILOT STUDY WITH CVS TO INFUSE THIS THERAPY AND MONITOR PATIENTS WITHIN THEIR OWN HOMES, WITH SKILLED NURSING PROFESSIONALS. CORAM LLC Office of Assistant Secretary for Preparedness and Response - HHS November 25, 2020 February 24, 2021 $494,000
ESTABLISHMENT OF HIGH THROUGHPUT SARS-COV-2 BINDING ANTIBODY IMMUNOASSAY CAPABILITY AND TESTING OF HUMAN SERUM SAMPLES PPD DEVELOPMENT, L.P. Office of Assistant Secretary for Preparedness and Response - HHS November 16, 2020 November 22, 2021 $2,750,095
DIASORIN SARS-COV-2 TRIMERICS IGG ASSAY&501(K) VALIDATION DIASORIN INC. Office of Assistant Secretary for Preparedness and Response - HHS November 10, 2020 November 09, 2021 $820,000
ACCULA FLU/SARS-COV-2 INTEGRATED TEST DEVELOPMENT MESA BIOTECH, INC. Office of Assistant Secretary for Preparedness and Response - HHS November 05, 2020 November 04, 2021 $12,991,595
SIEMENS HEALTHINEERS DEVELOPMENT OF SARS-COV-2 ANTIGEN TEST (COV2AG) FOR THE ADVIA CENTAUR AND ATELLICA IM SYSTEMS SIEMENS HEALTHCARE DIAGNOSTICS INC. Office of Assistant Secretary for Preparedness and Response - HHS November 02, 2020 November 01, 2021 $13,000,000
APTIMA SARS-COV-2 TESTS ON HOLOGIC PANTHER SYSTEMS HOLOGIC, INC. Office of Assistant Secretary for Preparedness and Response - HHS August 04, 2020 August 03, 2021 $2,429,380
DIASORIN LIAISON SARS-COV-2 S1/S2 IGG DIASORIN INC. Office of Assistant Secretary for Preparedness and Response - HHS April 10, 2020 February 03, 2021 -$55,045
CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING ASTRAZENECA PHARMACEUTICALS LP Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 October 31, 2020 $0
CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING ASTRAZENECA PHARMACEUTICALS LP Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 October 31, 2020 $0
FFP PURCHASE ORDER FOR SITE REIMBURSEMENT, ORTHO TESTING, NAB TESTING, AND TREATMENT/CONTROL STUDY AT THE MAYO CLINIC CCP EAP MAYO CLINIC Office of Assistant Secretary for Preparedness and Response - HHS July 01, 2020 June 30, 2021 $17,509,398
PROVIDE FOR CONSIDERATION / OFFSET IN COST FOR DOD PERSONNEL AGREEMENT EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC Office of Assistant Secretary for Preparedness and Response - HHS May 24, 2020 December 31, 2021 $0
CHANGE IN OTAO AND OTAS OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING ASTRAZENECA PHARMACEUTICALS LP Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 October 31, 2020 $0
THIRD NO-COST EXTENSION FOR EXPIRATION OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING ASTRAZENECA PHARMACEUTICALS LP Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 October 31, 2020 $0
BECKMAN COULTER - MONOCYTE DISTRIBUTION WIDTH (MDW) FOR RAPID DETECTION OF MIS-C ASSOCIATED WITH COVID-19 IN PEDIATRIC PATIENTS BECKMAN COULTER, INC. Office of Assistant Secretary for Preparedness and Response - HHS September 28, 2020 December 31, 2021 $694,000
INTEGRATE SARS-COV-2 WITH NXTAG? RESPIRATORY PATHOGEN PANEL AND SUBMIT 510(K) LUMINEX CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS September 24, 2020 September 23, 2021 $5,389,813
DEVELOPMENT OF A MOLECULAR DIAGNOSTIC TEST TO DETECT SARS-COV-2 USING THE HOLOGIC PANTHER FUSION? SYSTEM HOLOGIC, INC. Office of Assistant Secretary for Preparedness and Response - HHS July 06, 2020 September 24, 2020 $0
LUMINEX XMAP SARS-COV-2 MULTI-ANTIGEN ANTIBODY TYPING ASSAY LUMINEX CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS September 23, 2020 July 30, 2021 $683,500
TANGEN SARS-COV-2 ASSAY - NCE TO ALLOW TIME FOR THE EUA TO MOVE THROUGH FDA APPROVAL. TANGEN BIOSCIENCES, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 15, 2020 October 31, 2020 $0
UPDATE FAR CLAUSES IN TASK ORDER EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC Office of Assistant Secretary for Preparedness and Response - HHS May 24, 2020 December 31, 2021 $0
ADVIA CENTAUR SARS-COV-2 TOTAL , ATELLICA IM SARS-COV-2 TOTAL (COV2T) SIEMENS HEALTHCARE DIAGNOSTICS INC. Office of Assistant Secretary for Preparedness and Response - HHS September 17, 2020 September 16, 2021 $13,000,000
EXTEND FOR EXPIRATION OF ADVANCED AGREEMENT FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING ASTRAZENECA PHARMACEUTICALS LP Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 October 31, 2020 $0
98POINT6 TEXT-BASED MEDICAL CARE VIA A SMARTPHONE INTERFACE AND ARTIFICIAL INTELLIGENCE TO ASSESS, TRIAGE, DIAGNOSE AND TREAT COVID-19 98POINT6 INC. Office of Assistant Secretary for Preparedness and Response - HHS September 11, 2020 April 30, 2021 $700,000
CRO ASSISTANCE FOR THE ACTIV-1 MASTER PROTOCOL TECHNICAL RESOURCES INC Office of Assistant Secretary for Preparedness and Response - HHS August 17, 2020 August 16, 2021 $69,824,321
TO DEVELOP RAPID AND ACCURATE POINT OF CARE AND OVER THE COUNTER TESTS FOR DETECTION OF SARS-COV-2 ANTIBODIES IN BLOOD AND ACHIEVE EMERGENCY USE AUTHORIZATION (EUA). NOWDIAGNOSTICS, INC. Office of Assistant Secretary for Preparedness and Response - HHS August 28, 2020 April 27, 2021 $695,500
ORTHO CLINICAL DEVELOPMENT OF VITROS MICROWELL ASSAYS FOR TOTAL AND IGG ANTIBODIES TO SARS-COV-2 ORTHO-CLINICAL DIAGNOSTICS, INC. Office of Assistant Secretary for Preparedness and Response - HHS June 12, 2020 September 30, 2020 $0
ISSUE EXTENSION OF TARGET DATE OF DEFINITIZATION OF ADVANCED AGREEMENT FOR OTHER TRANSACTION AGREEMENT (OTA)FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING ASTRAZENECA PHARMACEUTICALS LP Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 October 31, 2020 $0
COVID-19 - MESA BIOTECH, INC. - RESEARCH&DEVELOPMENT OF QUALITATIVE, VISUALLY-READ PCR TEST. MESA TECH INTERNATIONAL, INC. Office of Assistant Secretary for Preparedness and Response - HHS March 13, 2020 August 07, 2020 $0
COVID-19 - SIEMENS - R&D OF AN AUTOMATED IMMUNOASSAY SIEMENS HEALTHCARE DIAGNOSTICS INC. Office of Assistant Secretary for Preparedness and Response - HHS May 28, 2020 April 01, 2021 $0
UPGRADE TASK ORDER TO A DEFENSE PRIORITIES ALLOCATIONS SYSTEM RATING TASK ORDER EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC Office of Assistant Secretary for Preparedness and Response - HHS May 24, 2020 December 31, 2021 $0
VERNDARI, INC. VERNDARI, INC. Office of Assistant Secretary for Preparedness and Response - HHS July 24, 2020 June 30, 2021 $0
UCONN - SINGLE-ADMINISTRATION MICRONEEDLE SKIN PATCH FOR NOVEL VACCINATION TECHNOLOGY UNIVERSITY OF CONNECTICUT Office of Assistant Secretary for Preparedness and Response - HHS August 18, 2020 August 31, 2021 $432,990
TANGEN SARS-COV-2 ASSAY TANGEN BIOSCIENCES, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 15, 2020 October 31, 2020 $0
COVID-19 - VELA DIAGNOSTICS USA INC.- RESEARCH&DEVELOPMENT OF PROBE-BASED REVERSE TRANSCRIPTASE PCR TEST. VELA DIAGNOSTICS USA INC. Office of Assistant Secretary for Preparedness and Response - HHS March 27, 2020 October 31, 2020 $0
LUMINEX DEVELOPMENT OF ARIES SARS-COV-2 ASSAY LUMINEX CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS March 27, 2020 August 07, 2020 $0
VAXESS - MIMIX-COVID PRE-FUSION SPIKE PROTEIN VACCINE PATCH MFG: SCALING TO 100M UNITS OF SHELF-STABLE, SELF-APPLIED, SINGLE-DOSE VACCINE VAXESS TECHNOLOGIES INC Office of Assistant Secretary for Preparedness and Response - HHS August 10, 2020 June 30, 2021 $749,000
APTIMA SARS-COV-2 TESTS ON HOLOGIC PANTHER SYSTEMS HOLOGIC, INC. Office of Assistant Secretary for Preparedness and Response - HHS August 04, 2020 August 03, 2021 $8,912,000
I. AMENDMENT PURPOSE: BY THE PARTIES? MUTUAL AGREEMENT AND WITHIN THE EXISTING AGREEMENT?S GENERAL SCOPE, THIS AMENDMENT NO. 0007 BILATERALLY ACCOMPLISHES THE FOLLOWING: A. EXTEND THE PERIOD OF PERFORMANCE OF CLIN 0001A FROM 31 JULY 2020 TO 30 JUNE JANSSEN RESEARCH & DEVELOPMENT, LLC Office of Assistant Secretary for Preparedness and Response - HHS September 21, 2018 December 31, 2024 $0
VERNDARI, INC. VERNDARI, INC. Office of Assistant Secretary for Preparedness and Response - HHS July 24, 2020 June 30, 2021 $698,215
COVID-19 - RAPID ANTIGEN AND ANTIBODY TEST NANOMIX, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 02, 2020 November 30, 2020 $0
SUPPLEMENTAL WORK-SARS-COV-2 HUMANETICS CORPORATION National Institutes of Health March 29, 2018 June 30, 2022 $2,137,190
GENMARK DX EPLEX RESPIRATORY PATHOGEN V2 PANEL GENMARK DIAGNOSTICS, INC. Office of Assistant Secretary for Preparedness and Response - HHS March 20, 2020 September 30, 2020 $0
COVID-19 - CHEMBIO DIAGNOSTICS INC - R&D OF A SARS-COV-2 AG SYSTEM CHEMBIO DIAGNOSTIC SYSTEMS INC. Office of Assistant Secretary for Preparedness and Response - HHS July 05, 2020 January 29, 2021 $0
EVIDATION COVID-19 DETECTION&FORECASTING MODEL PILOT EVIDATION HEALTH, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 20, 2020 September 30, 2021 $0
COVID-19 -- INBIOS R&D OF AN ANTIBODY DIAGNOSTIC INBIOS INTERNATIONAL INC Office of Assistant Secretary for Preparedness and Response - HHS April 24, 2020 December 01, 2020 $155,055
DIASORIN LIAISON SARS-COV-2 S1/S2 IGG DIASORIN INC. Office of Assistant Secretary for Preparedness and Response - HHS April 10, 2020 February 03, 2021 $111,090
COVID-19 - CHEMBIO DIAGNOSTICS INC - R&D OF A SARS-COV-2 AG SYSTEM CHEMBIO DIAGNOSTIC SYSTEMS INC. Office of Assistant Secretary for Preparedness and Response - HHS July 05, 2020 January 29, 2021 $628,071
LUMINEX NXTAG COV EXTENDED PANEL DEVELOPMENT LUMINEX CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS March 26, 2020 July 01, 2020 $0
HEMEMICS HEMBOX: A RAPID, POINT-OF-CARE DIAGNOSTIC TOOL FOR NOVEL VIRUSES HEMEMICS BIOTECHNOLOGIES, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 09, 2020 July 01, 2020 $0
COLORADO STATE VACCINE DEVELOPMENT FOR COVID-19 USING SOLAVAX COLORADO STATE UNIVERSITY Office of Assistant Secretary for Preparedness and Response - HHS March 31, 2021 July 30, 2021 $699,994
AN NHP EFFICACY STUDY OF BIO 300 FOR MITIGATOR FOR DEARE-INDUCED PNEUMONITIS AND PULMONARY FIBROSIS. SARS COV-2 HUMANETICS CORPORATION National Institutes of Health March 29, 2018 June 30, 2022 $503,859
ADDED A SUPPLEMENT FOR KEVZARA. THIS COVERS THE OVER-RECRUITMENT OF 1,470 PARTICIPANTS. REGENERON PHARMACEUTICALS, INC. Office of Assistant Secretary for Preparedness and Response - HHS September 21, 2017 May 31, 2026 $53,517,946
EMPATICA EMPACT: EARLY MONITORING PLATFORM AGAINST COVID-19 TRANSMISSION EMPATICA, INC. Office of Assistant Secretary for Preparedness and Response - HHS June 18, 2020 April 30, 2021 $717,807
MBIO HIGH PERFORMANCE POINT-OF-CARE ANTIBODY TEST TO ASSESS IMMUNITY TO SARS-COV-2 VIRUS AND CONFIRM POSITIVE ANTIBODY TESTS MBIO DIAGNOSTICS, INC. Office of Assistant Secretary for Preparedness and Response - HHS June 17, 2020 March 31, 2021 $629,595
ORTHO CLINICAL DEVELOPMENT OF VITROS MICROWELL ASSAYS FOR TOTAL AND IGG ANTIBODIES TO SARS-COV-2 ORTHO-CLINICAL DIAGNOSTICS, INC. Office of Assistant Secretary for Preparedness and Response - HHS June 12, 2020 September 30, 2020 $678,000
IMMUNEXPRESS ASSESSMENT&TRIAGE OF PATIENTS WITH ESCALATING SIGNS OF COVID-19 DISEASE USING A HOST RESPONSE TEST FOR SEPSIS IMMUNEXPRESS INC. Office of Assistant Secretary for Preparedness and Response - HHS June 11, 2020 December 31, 2021 $599,549
COVID-19 - R&D OF AN ANTIBODY TEST ORASURE TECHNOLOGIES, INC. Office of Assistant Secretary for Preparedness and Response - HHS June 04, 2020 April 01, 2021 $629,217
HEMEMICS HEMBOX: A RAPID, POINT-OF-CARE DIAGNOSTIC TOOL FOR NOVEL VIRUSES HEMEMICS BIOTECHNOLOGIES, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 09, 2020 July 01, 2020 -$613,000
COVID-19 - SNAPDRAGON CHEMISTRY - R&D OF A CONTINUOUS MANUFACTURING PLATFORM SNAPDRAGON CHEMISTRY, INC. Office of Assistant Secretary for Preparedness and Response - HHS May 29, 2020 May 01, 2021 $691,878
COVID-19 - QUIDEL - ANTIGEN ASSAY QUIDEL CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS May 29, 2020 April 08, 2021 $634,644
COVID-19 - VITAL CONNECT, INC. - R&D FOR SYSTEM AND ALGORITHM OPTIMIZATION FOR PATIENT POPULATION REPORTS&OTHER DELIVERABLES VITAL CONNECT, INC. Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 January 15, 2021 $0
COVID-19 - SIEMENS - R&D OF AN AUTOMATED IMMUNOASSAY SIEMENS HEALTHCARE DIAGNOSTICS INC. Office of Assistant Secretary for Preparedness and Response - HHS May 28, 2020 April 01, 2021 $602,275
EMERGENT CIADM MANUFACTURING CAPACITY RESERVATION AND EXPANSION EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC Office of Assistant Secretary for Preparedness and Response - HHS May 24, 2020 December 31, 2021 $628,250,000
COVID-19 - VITAL CONNECT, INC. - R&D FOR SYSTEM AND ALGORITHM OPTIMIZATION FOR PATIENT POPULATION REPORTS&OTHER DELIVERABLES VITAL CONNECT, INC. Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 January 15, 2021 $592,791
ISSUE ADVANCED AGREEMENT PRIOR TO AWARD OF AN OTHER TRANSACTION AGREEMENT (OTA)FOR THE COVID19 VACCINE DEVELOPMENT AND MANUFACTURING ASTRAZENECA PHARMACEUTICALS LP Office of Assistant Secretary for Preparedness and Response - HHS May 20, 2020 October 31, 2020 $413,200,000
A MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, MULTI-ARM HISTORICAL CONTROL, COMPARATIVE TRIAL OF THE SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AND THE COMBINATION OF HYDROXYCHLOROQUINE AND FAMOTIDINE FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 DISEASE ALCHEM LABORATORIES CORP Office of Assistant Secretary for Preparedness and Response - HHS April 14, 2020 September 30, 2020 $0
PROJECT RTOR BIO-AMT-1021: DEVELOPMENT OF ANIMAL MODELS FOR EVALUATION OF MEDICAL COUNTERMEASURES FOR SARS-COV-2 LOVELACE BIOMEDICAL & ENVIRONMENTAL RESEARCH INSTITUTE INC Office of Assistant Secretary for Preparedness and Response - HHS March 30, 2020 June 30, 2021 $2,177,532
EXPANDING PRODUCTION CAPACITY FOR THE PANTHER FUSION SARS-COV-2 ASSAY HOLOGIC, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 29, 2020 April 28, 2021 $13,000,000
COVID-19 -- INBIOS R&D OF AN ANTIBODY DIAGNOSTIC INBIOS INTERNATIONAL INC Office of Assistant Secretary for Preparedness and Response - HHS April 24, 2020 December 01, 2020 $594,943
THIS MODIFICATION 11 (ELEVEN) ACCOMPLISHES THE FOLLOWING: 1.) SUPPLEMENTAL FUNDING IN THE AMOUNT OF $12,736,273 PROVIDED FOR BASE PERIOD (CLIN 0001) 2.) PERIOD OF PERFORMANCE OF BASE PERIOD (CLIN 0001 - A AND B) IS EXTENDED FROM 6/30/2020 TO 6/30 CERUS CORPORATION Office of Assistant Secretary for Preparedness and Response - HHS June 17, 2016 December 31, 2021 $13,779,657
EVIDATION COVID-19 DETECTION&FORECASTING MODEL PILOT EVIDATION HEALTH, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 20, 2020 September 30, 2021 $720,000
TANGEN SARS-COV-2 ASSAY TANGEN BIOSCIENCES, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 15, 2020 October 31, 2020 $696,000
A MULTI-SITE, RANDOMIZED, DOUBLE-BLIND, MULTI-ARM HISTORICAL CONTROL, COMPARATIVE TRIAL OF THE SAFETY AND EFFICACY OF HYDROXYCHLOROQUINE AND THE COMBINATION OF HYDROXYCHLOROQUINE AND FAMOTIDINE FOR THE TREATMENT OF MODERATE TO SEVERE COVID-19 DISEASE ALCHEM LABORATORIES CORP Office of Assistant Secretary for Preparedness and Response - HHS April 14, 2020 September 30, 2020 $20,747,018
COVID-19 THE PURPOSE OF THIS MODIFICATION IS (1) EXTEND THE PERIOD OF PERFORMANCE FOR THE BASE PERIOD FROM MAY 31,2020 THROUGH SEPTEMBER 30, 2024, WITHOUT ADDITIONAL COSTS TO THE GOVERNMENT; (2) EXERCISE OPTIONS ONE (1) AND TWO (2); AND (3) REVISE TH MERCK SHARP & DOHME CORP. Office of Assistant Secretary for Preparedness and Response - HHS August 29, 2016 September 30, 2024 $38,033,570
DIASORIN LIAISON SARS-COV-2 S1/S2 IGG DIASORIN INC. Office of Assistant Secretary for Preparedness and Response - HHS April 10, 2020 February 03, 2021 $180,045
HEMEMICS HEMBOX: A RAPID, POINT-OF-CARE DIAGNOSTIC TOOL FOR NOVEL VIRUSES HEMEMICS BIOTECHNOLOGIES, INC. Office of Assistant Secretary for Preparedness and Response - HHS April 09, 2020 July 01, 2020 $638,000
‹ Previous 1
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.
Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page